Document is current
Any future updates will be listed below
-
Authors
Haberman, Rebecca H.
Chen, Kyra
Howe, Catherine
Um, Seungha
Felipe, Adamary
Fu, Brianna
Eichman, Stephanie
Coyle, Margaret
Lydon, Eileen
Neimann, Andrea L.
Reddy, Soumya M.
Adhikari, Samrachana
Scher, Jose U.
-
Funding
Funding for this research was provided by:
National Institutes of Health (1UC2AR081029, R01AR084274, 1K23AR082955, 3UC2AR081039-02S1 , T32-AR-069515, 1UC2AR081029, R01AR084274, 1K23AR082955, 3UC2AR081039-02S1 , T32-AR-069515, 1UC2AR081029, R01AR084274, 1K23AR082955, 3UC2AR081039-02S1 , T32-AR-069515)
NYU Colton Center for Autoimmunity
Rheumatology Research Foundation
National Psoriasis Foundation
The Beatrice Snyder Foundation
The Riley Family Foundation
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 24 February 2025
First Online: 4 March 2025
Declarations
:
: The study was approved by the NYU Institutional Review Board (s20-00084) with waived written consent from individual participants as all data was collected in a deidentified manner.
: Not applicable.
: RHH has served as a consultant for Johnson & Johnson and Novartis. SMR has served as a consultant for BMS, Johnson & Johnson, Novartis and UCB. JUS has served as a consultant for BMS, Johnson & Johnson, Pfizer, and UCB. EL has served as a consultant for Amgen, AstraZeneca, and UCB. ALN has served as a consultant for Sun pharma and UCB.
